Allergan Lifts 2018 Adj. Profit And Net Revenue Outlook

(RTTNews) - Allergan plc (AGN) said that it raised full-year 2018 net revenue and non-GAAP performance net income per share guidance.

For 2018, the company now expects loss per share to be in the range of $2.95- $3.36, and non-GAAP earnings per share of $16.20 - $16.60. Previously, the company expected loss per share to be in the range of $2.57 - $3.08, and non-GAAP earnings per share of $16.00 - $16.50.

The company now projects annual total net revenue of $15.575 billion - $15.725 billion, and non-GAAP total net revenue of $15.550 billion - $15.700 billion. Earlier, the company anticipated total net revenue of $15.475 billion - $15.625 billion, and non-GAAP total net revenue of $15.450 billion - $15.600 billion.

Analysts polled by Thomson Reuters expect the company to report earnings of $16.38 per share and revenues of $15.61 billion for 2018. Analysts' estimates typically exclude special items.